Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Approval of Tafenoquine for Malaria Chemoprophylaxis.

Berman JD.

Am J Trop Med Hyg. 2019 Jun;100(6):1301-1304. doi: 10.4269/ajtmh.19-0001.

PMID:
30887947
2.

Singular dynamics in the failure of soft adhesive contacts.

Berman JD, Randeria M, Style RW, Xu Q, Nichols JR, Duncan AJ, Loewenberg M, Dufresne ER, Jensen KE.

Soft Matter. 2019 Feb 6;15(6):1327-1334. doi: 10.1039/c8sm02075b.

PMID:
30540331
3.

Developing a geostatistical simulation method to inform the quantity and placement of new monitors for a follow-up air sampling campaign.

Berman JD, Jin L, Bell ML, Curriero FC.

J Expo Sci Environ Epidemiol. 2019 Mar;29(2):248-257. doi: 10.1038/s41370-018-0073-6. Epub 2018 Sep 20.

PMID:
30237550
4.

School environmental conditions and links to academic performance and absenteeism in urban, mid-Atlantic public schools.

Berman JD, McCormack MC, Koehler KA, Connolly F, Clemons-Erby D, Davis MF, Gummerson C, Leaf PJ, Jones TD, Curriero FC.

Int J Hyg Environ Health. 2018 Jun;221(5):800-808. doi: 10.1016/j.ijheh.2018.04.015. Epub 2018 May 2.

5.

Optimizing a Sensor Network with Data from Hazard Mapping Demonstrated in a Heavy-Vehicle Manufacturing Facility.

Berman JD, Peters TM, Koehler KA.

Ann Work Expo Health. 2018 May 28;62(5):547-558. doi: 10.1093/annweh/wxy020.

PMID:
29562311
6.

Drought and the risk of hospital admissions and mortality in older adults in western USA from 2000 to 2013: a retrospective study.

Berman JD, Ebisu K, Peng RD, Dominici F, Bell ML.

Lancet Planet Health. 2017 Apr;1(1):e17-e25. doi: 10.1016/S2542-5196(17)30002-5. Epub 2017 Apr 12.

7.

Exposure to coarse particulate matter during gestation and birth weight in the U.S.

Ebisu K, Berman JD, Bell ML.

Environ Int. 2016 Sep;94:519-524. doi: 10.1016/j.envint.2016.06.011. Epub 2016 Jun 18.

8.

Health benefits from large-scale ozone reduction in the United States.

Berman JD, Fann N, Hollingsworth JW, Pinkerton KE, Rom WN, Szema AM, Breysse PN, White RH, Curriero FC.

Environ Health Perspect. 2012 Oct;120(10):1404-10. doi: 10.1289/ehp.1104851. Epub 2012 Jul 18.

9.

Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

Soto J, Rea J, Balderrama M, Toledo J, Soto P, Valda L, Berman JD.

Am J Trop Med Hyg. 2008 Feb;78(2):210-1.

PMID:
18256415
10.

Development of miltefosine for the leishmaniases.

Berman JD.

Mini Rev Med Chem. 2006 Feb;6(2):145-51. Review.

PMID:
16472183
11.

Advances in leishmaniasis.

Murray HW, Berman JD, Davies CR, Saravia NG.

Lancet. 2005 Oct 29-Nov 4;366(9496):1561-77. Review.

PMID:
16257344
12.

Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.

Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD.

Am J Trop Med Hyg. 2005 Feb;72(2):133-7.

PMID:
15741547
13.

Miltefosine for new world cutaneous leishmaniasis.

Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H.

Clin Infect Dis. 2004 May 1;38(9):1266-72. Epub 2004 Apr 9.

PMID:
15127339
14.

Implementing a research agenda for complementary and alternative medicine.

Berman JD, Straus SE.

Annu Rev Med. 2004;55:239-54. Review.

PMID:
14746520
15.

Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.

Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson AD, Berman JD.

Clin Infect Dis. 2004 Jan 15;38(2):217-21. Epub 2003 Dec 18.

PMID:
14699453
16.

Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.

Sundar S, Sahu M, Mehta H, Gupta A, Kohli U, Rai M, Berman JD, Murray HW.

Clin Infect Dis. 2002 Sep 1;35(5):581-6. Epub 2002 Jul 31.

PMID:
12173133
17.

Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.

Soto JM, Toledo JT, Gutierrez P, Arboleda M, Nicholls RS, Padilla JR, Berman JD, English CK, Grogl M.

Am J Trop Med Hyg. 2002 Feb;66(2):147-51.

PMID:
12135285
18.

Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model.

Berman JD, Nielsen R, Chulay JD, Dowler M, Kain KC, Kester KE, Williams J, Whelen AC, Shmuklarsky MJ.

Trans R Soc Trop Med Hyg. 2001 Jul-Aug;95(4):429-32.

PMID:
11579890
19.

Focus on independence.

Berman JD, Hudson D.

J Med Assoc Ga. 1999 Dec;88(4):48-50. No abstract available.

PMID:
10666996
20.

Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.

Valli LC, Passos VM, Dietze R, Callahan HL, Berman JD, Grogl M.

J Parasitol. 1999 Dec;85(6):1076-83.

PMID:
10647040
21.
22.
23.

A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate.

Sundar S, Sinha PR, Agrawal NK, Srivastava R, Rainey PM, Berman JD, Murray HW, Singh VP.

Am J Trop Med Hyg. 1998 Jul;59(1):139-43.

PMID:
9684642
24.

Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.

Berman JD, Badaro R, Thakur CP, Wasunna KM, Behbehani K, Davidson R, Kuzoe F, Pang L, Weerasuriya K, Bryceson AD.

Bull World Health Organ. 1998;76(1):25-32.

25.

Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial.

Oldfield EC 3rd, Fessel WJ, Dunne MW, Dickinson G, Wallace MR, Byrne W, Chung R, Wagner KF, Paparello SF, Craig DB, Melcher G, Zajdowicz M, Williams RF, Kelly JW, Zelasky M, Heifets LB, Berman JD.

Clin Infect Dis. 1998 Mar;26(3):611-9.

PMID:
9524832
26.

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya.

Andersen SL, Oloo AJ, Gordon DM, Ragama OB, Aleman GM, Berman JD, Tang DB, Dunne MW, Shanks GD.

Clin Infect Dis. 1998 Jan;26(1):146-50.

PMID:
9455524
27.

Cytostatic effect of TNFalpha on cancer cells is independent of p21WAF1.

Shiohara M, Gombart AF, Berman JD, Koike K, Komiyama A, Koeffler HP.

Oncogene. 1997 Sep 25;15(13):1605-9.

28.

Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A.

Gombart AF, Yang R, Campbell MJ, Berman JD, Koeffler HP.

Leukemia. 1997 Oct;11(10):1673-80.

PMID:
9324288
29.

Acetylcholine exocytosis in PC12 cells deficient in SNAP-25.

Ray P, Millard CB, Petrali JP, Berman JD, Ray R.

Neuroreport. 1997 Jul 7;8(9-10):2271-4.

PMID:
9243624
30.
31.

Treatment of New World cutaneous and mucosal leishmaniases.

Berman JD.

Clin Dermatol. 1996 Sep-Oct;14(5):519-22.

PMID:
8889330
32.

In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.

Roberts WL, Berman JD, Rainey PM.

Antimicrob Agents Chemother. 1995 Jun;39(6):1234-9.

33.

Paromomycin resistance in Leishmania tropica: lack of correlation with mutation in the small subunit ribosomal RNA gene.

Fong D, Chan MM, Rodriguez R, Gately LJ, Berman JD, Grogl M.

Am J Trop Med Hyg. 1994 Dec;51(6):758-66.

PMID:
7810808
34.

Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis.

Franke ED, Llanos-Cuentas A, Echevarria J, Cruz ME, Campos P, Tovar AA, Lucas CM, Berman JD.

Am J Trop Med Hyg. 1994 Jul;51(1):77-82.

PMID:
8059918
35.
36.
37.

Inhibition of bioenergetics alters intracellular calcium, membrane composition, and fluidity in a neuronal cell line.

Ray P, Ray R, Broomfield CA, Berman JD.

Neurochem Res. 1994 Jan;19(1):57-63.

PMID:
8139764
38.

Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.

Gasser RA Jr, Magill AJ, Oster CN, Franke ED, Grögl M, Berman JD.

Clin Infect Dis. 1994 Jan;18(1):83-90.

PMID:
7519887
39.

Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion).

Dietze R, Milan EP, Berman JD, Grogl M, Falqueto A, Feitosa TF, Luz KG, Suassuna FA, Marinho LA, Ksionski G.

Clin Infect Dis. 1993 Dec;17(6):981-6.

PMID:
8110956
40.
41.

Botulinum toxin inhibits arachidonic acid release associated with acetylcholine release from PC12 cells.

Ray P, Berman JD, Middleton W, Brendle J.

J Biol Chem. 1993 May 25;268(15):11057-64.

42.

Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia.

Soto-Mancipe J, Grogl M, Berman JD.

Clin Infect Dis. 1993 Mar;16(3):417-25.

PMID:
8384011
43.

Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.

Berman JD, Ksionski G, Chapman WL, Waits VB, Hanson WL.

Antimicrob Agents Chemother. 1992 Sep;36(9):1978-80.

44.

Allopurinol in the treatment of American cutaneous leishmaniasis.

Herwaldt BL, Neva FA, Berman JD.

N Engl J Med. 1992 Aug 13;327(7):498-9. No abstract available.

PMID:
1625745
45.

Sodium stibogluconate (Pentostam) overdose during treatment of American cutaneous leishmaniasis.

Herwaldt BL, Kaye ET, Lepore TJ, Berman JD, Baden HP.

J Infect Dis. 1992 May;165(5):968-71.

PMID:
1314873
46.

Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.

Queener SF, Dean RA, Bartlett MS, Milhous WK, Berman JD, Ellis WY, Smith JW.

J Infect Dis. 1992 Apr;165(4):764-8.

PMID:
1532406
47.
48.
49.

Pharmacokinetic justification of antiprotozoal therapy. A US perspective.

Berman JD, Fleckenstein L.

Clin Pharmacokinet. 1991 Dec;21(6):479-93. Review.

PMID:
1782741
50.

Cyanide sensitive and insensitive bioenergetics in a clonal neuroblastoma x glioma hybrid cell line.

Ray P, Monroe FL, Berman JD, Fiedler J.

Neurochem Res. 1991 Oct;16(10):1121-4.

PMID:
1795758

Supplemental Content

Loading ...
Support Center